Hy2Care BV is a spin-off company of the MIRA Institute of the University Twente, the Netherlands, one of the world’s leading institutes in biomedical and chemical engineering. Since 2007 more than 4 million EURO has been invested in developing a platform technology. We filed three patents in Europe and US and additional filing of IP is ongoing. Product prototyping and first animal testing have been completed. Our market study and face-to-face interviews with key opinion leaders confirm the strong interest of orthopedic surgeons with recognized international reputation to implement our products in their day-to-day practice
Location: Netherlands, Limburg, Geleen
Employees: 11-50
Total raised: $11.45M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Startupboo... | startupboo... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.05.2025 | - | $5.05M | - |
| 24.06.2022 | Grant | $6.4M | - |
Mentions in press and media 7
| Date | Title | Description |
| 21.05.2025 | Hy2Care's €4.5M Funding: A Leap Towards Cartilage Repair Innovation | In the world of medical technology, innovation is the lifeblood. Dutch medtech company Hy2Care has just secured €4.5 million in funding, a significant boost that could change the landscape of cartilage repair. This funding is not just a num... |
| 19.05.2025 | Hy2Care Raises €4.5M in Funding | Hy2Care, a Geleen, the Netherlands-based company that is advancing an injectable hydrogel, raised €4.5M in funding. Half of the funding came from the European Innovation Council (EIC) Fund investment awarded to Hy2Care in 2022 as part of th... |
| 16.05.2025 | Dutch medtech Hy2Care secures €4.5M to launch clinical trial for cartilage repair implant | Dutch medtech Hy2Care has raised €4.5 million in new funding to prepare for a clinical trial in the United States and to support early steps toward commercialisation in Europe and other global markets. Half of the new funding comes from the... |
| 30.12.2022 | Dutch-based biotech and life sciences startups that raised funding in 2022 | The Netherlands is swiftly rising to the top as a hub for healthcare and life sciences innovation. More and more Dutch startups are engaged in a range of cutting-edge initiatives, such as the creation of digital health tools, the developmen... |
| 12.07.2022 | EIC Accelerator: EIC announces major funding to 74 European startups; 5 are from the Netherlands | The European Commission (EC) announced on June 7 that it has selected 74 innovative companies under the first 2022 EIC Accelerator cut-off. The companies announced were among 1093 applicants who submitted to the first 2022 cut-off dated Mar... |
| 24.06.2022 | Hy2Care receives € 6M EU funding for optimal cartilage repair | Geleen, The Netherlands, 9 June 2022 The EIC Accelerator is a highly competitive program of the European Commission offering funding, coaching and business acceleration services to innovative small or medium-sized businesses with a scalabl... |
| - | Hy2Care | “Hy2Care develops in situ gelating bioresorbable hydrogels for the arthroscopic treatment of cartilage defects, aiming at functional cartilage repair.” |